Arvinas (ARVN) Change in Account Payables (2017 - 2022)
Arvinas (ARVN) recorded quarterly Change in Account Payables of -$22.6 million in Q1 2022, down 186.17% quarter-over-quarter from $26.2 million in Q4 2021, and down 1355.56% on a YoY basis from $1.8 million in Q1 2021.
Arvinas (ARVN) Change in Account Payables (2017 - 2022) Analysis & Trends
Arvinas' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$22.6 million for Q1 2022.
- In Q1 2022, Change in Account Payables fell 1355.56% year-over-year to -$22.6 million; the TTM figure through Mar 2022 stood at -$700000.0 (down 112.26% YoY), while the FY2021 annual figure was $23.7 million, up 1085.0% from the prior year.
- Change in Account Payables was -$22.6 million for Q1 2022 at Arvinas, down from $26.2 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $26.2 million in Q4 2021 to a low of -$22.6 million in Q1 2022.
- Historically, Change in Account Payables has averaged $388362.5 across 5 years, with a median of $284784.0 in 2019.
- The sharpest annual moves came in 2021 and 2022: Change in Account Payables soared 1067.29% in 2021, then tumbled 1355.56% in 2022.
- A 5-year view of Change in Account Payables shows it stood at $1.3 million in 2018, then jumped by 63.26% to $2.1 million in 2019, then increased by 6.03% to $2.2 million in 2020, then jumped by 1067.29% to $26.2 million in 2021, then sank by 186.17% to -$22.6 million in 2022.
- The last three Change in Account Payables figures came in at -$22.6 million (Q1 2022), $26.2 million (Q4 2021), and -$82863.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -22.60 Mn |
| Mar 31, 2022 | -22.60 Mn |
| Dec 31, 2021 | 26.23 Mn |
| Dec 31, 2021 | 26.23 Mn |
| Sep 30, 2021 | -82,863.00 |
| Sep 30, 2021 | -82,863.00 |
| Jun 30, 2021 | -4.24 Mn |
| Jun 30, 2021 | -4.24 Mn |
| Mar 31, 2021 | 1.80 Mn |
| Mar 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 2.25 Mn |
| Dec 31, 2020 | 2.25 Mn |
| Sep 30, 2020 | 2.03 Mn |
| Sep 30, 2020 | 2.03 Mn |
| Jun 30, 2020 | -367,912.00 |
| Jun 30, 2020 | -367,912.00 |
| Mar 31, 2020 | -1.91 Mn |
| Mar 31, 2020 | -1.91 Mn |
| Dec 31, 2019 | 2.12 Mn |
| Dec 31, 2019 | 2.12 Mn |